Sequent Scientific Limited has completed the allotment of 13,61,60,231 equity shares to CA Hull Investments, as part of a composite scheme of amalgamation. This allotment, executed on December 16, 2025, follows the sanction of the scheme by the National Company Law Tribunal, Hyderabad bench, on November 18, 2025. The share exchange ratio for this transaction was 56 fully paid-up equity shares of Sequent (face value ₹2) for every 100 fully paid-up equity shares of Viyash Life Sciences Private Limited (face value ₹10). Consequently, CA Hull Investments now holds 31.20% of Sequent's total paid-up share capital. This allotment is exempt from open offer obligations under Regulation 10(1)(d)(ii) of the SEBI Takeover Regulations, as it is pursuant to a court-approved scheme of arrangement. Post-transaction, CA Hull Investments holds 13,61,60,231 shares (31.20%), and CA Harbor Investments holds 13,16,80,103 shares (30.20%), bringing the total promoter group holding to 61.40% of Sequent's total share capital.